What does Medtradex do?

Medtradex is a wholesaler in Oud-Heverlee. Private Limited, started on 27 July 2018, 2 establishments.

What is the address of Medtradex?

The registered office of Medtradex is located at Korbeekdamstraat 30A, 3050 Oud-Heverlee.

Is Medtradex still active?

Yes. According to the CBE (30 October 2026) Medtradex is active, legal situation “Normale toestand”, started on 27 July 2018.

Is Medtradex registered on Peppol?

Yes, Medtradex is registered on the Peppol network with ID 0208:0700451252.

What is the enterprise number of Medtradex?

The enterprise number of Medtradex is BE0700451252.

When was Medtradex founded?

Medtradex was founded on 27 July 2018.

Who are the directors of Medtradex?

According to the 2025 annual accounts, the directors of Medtradex are: Céline Simonet, Ivo Schapdryver.

Is Medtradex a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 July 2018; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did Medtradex make in 2025?

Medtradex posted a profit after taxes of € 14,423 in financial year 2025.

What is the revenue of Medtradex?

As a small company, Medtradex is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 593,716.

How much does an employee at Medtradex earn?

The average wage cost per full-time employee at Medtradex was € 77,900 in 2025: staff costs of € 397,480 for 5.1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Medtradex have?

According to the 2025 annual accounts, Medtradex has 5.1 full-time equivalents (FTE).

Medtradex (Private Limited) - Oud-Heverlee - BE0700451252

Dossier Medtradex, printed on 30 October 2026 from databakkes.be/en/0700451252/medtradex. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Medtradex from Oud-Heverlee, company number BE0700451252, closed financial year 2025 with a result of € 14,423 after tax. For that financial year Medtradex recorded a gross margin of € 593,716 and equity of € 270,917. Compared with financial year 2024, the result moved from € 61,965 to € 14,423. The company is profitable. The buffer shrank hard: equity is 56 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.

What it is worth Shrank hard

€ 270,917

▼ 56% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 14,423

▼ 77% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 227,294

▼ 29% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 357,951 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

5.1

▲ 0.4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 397,480

▲ 9% vs 2024

€ 77,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 34,726

▼ 35% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 50,000

▼ 33% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 189,502

▼ 37% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 68,148

▼ 11% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 849,002 Gross margin 2022: € 849,002 First fiscal year in the series	€ 968,061 Gross margin 2023: € 968,061 ▲ 14% vs 2022 (€ 849,002) Favourable step	€ 586,636 Gross margin 2024: € 586,636 ▼ 39% vs 2023 (€ 968,061) Unfavourable step	€ 593,716 Gross margin 2025: € 593,716 ▲ 1% vs 2024 (€ 586,636) Favourable step	▲ 1%
Profit after taxes	€ 289,528 Profit after taxes 2022: € 289,528 First fiscal year in the series	€ 279,138 Profit after taxes 2023: € 279,138 ▼ 4% vs 2022 (€ 289,528) Unfavourable step	€ 61,965 Profit after taxes 2024: € 61,965 ▼ 78% vs 2023 (€ 279,138) Unfavourable step	€ 14,423 Profit after taxes 2025: € 14,423 ▼ 77% vs 2024 (€ 61,965) Unfavourable step	▼ 77%
Equity	€ 1,342,946 Equity 2022: € 1,342,946 First fiscal year in the series	€ 1,622,084 Equity 2023: € 1,622,084 ▲ 21% vs 2022 (€ 1,342,946) Favourable step	€ 614,445 Equity 2024: € 614,445 ▼ 62% vs 2023 (€ 1,622,084) Unfavourable step	€ 270,917 Equity 2025: € 270,917 ▼ 56% vs 2024 (€ 614,445) Unfavourable step	▼ 56%
Total debts	€ 1,260,873 Total debts 2022: € 1,260,873 First fiscal year in the series	€ 1,183,685 Total debts 2023: € 1,183,685 ▼ 6% vs 2022 (€ 1,260,873) Favourable step	€ 452,281 Total debts 2024: € 452,281 ▼ 62% vs 2023 (€ 1,183,685) Favourable step	€ 616,848 Total debts 2025: € 616,848 ▲ 36% vs 2024 (€ 452,281) Unfavourable step	▲ 36%
Cash	€ 591,635 Cash 2022: € 591,635 First fiscal year in the series	€ 913,366 Cash 2023: € 913,366 ▲ 54% vs 2022 (€ 591,635) Favourable step	€ 321,999 Cash 2024: € 321,999 ▼ 65% vs 2023 (€ 913,366) Unfavourable step	€ 227,294 Cash 2025: € 227,294 ▼ 29% vs 2024 (€ 321,999) Unfavourable step	▼ 29%
Land & buildings	€ 878,282 Land & buildings 2022: € 878,282 First fiscal year in the series	€ 852,698 Land & buildings 2023: € 852,698 ▼ 3% vs 2022 (€ 878,282) Unchanged	€ 0 Land & buildings 2024: € 0 ▼ 100% vs 2023 (€ 852,698) Unchanged	-
Retained profit	€ 1,292,946 Retained profit 2022: € 1,292,946 First fiscal year in the series	€ 1,572,084 Retained profit 2023: € 1,572,084 ▲ 22% vs 2022 (€ 1,292,946) Favourable step	€ 597,415 Retained profit 2024: € 597,415 ▼ 62% vs 2023 (€ 1,572,084) Unfavourable step	€ 253,887 Retained profit 2025: € 253,887 ▼ 58% vs 2024 (€ 597,415) Unfavourable step	▼ 58%
Dividend	€ 117,647 Dividend 2022: € 117,647 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 117,647) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 357,951 Dividend 2025: € 357,951 Unchanged (€ 0) Unchanged
Bank debt	€ 838,068 Bank debt 2022: € 838,068 First fiscal year in the series	€ 697,356 Bank debt 2023: € 697,356 ▼ 17% vs 2022 (€ 838,068) Favourable step	€ 74,442 Bank debt 2024: € 74,442 ▼ 89% vs 2023 (€ 697,356) Favourable step	€ 50,000 Bank debt 2025: € 50,000 ▼ 33% vs 2024 (€ 74,442) Favourable step	▼ 33%
Balance sheet total	€ 2,603,819 Balance sheet total 2022: € 2,603,819 First fiscal year in the series	€ 2,805,769 Balance sheet total 2023: € 2,805,769 ▲ 8% vs 2022 (€ 2,603,819) Unchanged	€ 1,066,726 Balance sheet total 2024: € 1,066,726 ▼ 62% vs 2023 (€ 2,805,769) Unchanged	€ 952,747 Balance sheet total 2025: € 952,747 ▼ 11% vs 2024 (€ 1,066,726) Unchanged	▼ 11%
Employees (FTE)	4 Employees (FTE) 2022: 4 First fiscal year in the series	4.6 Employees (FTE) 2023: 4.6 ▲ 0.6 vs 2022 (4) Unchanged	4.7 Employees (FTE) 2024: 4.7 ▲ 0.1 vs 2023 (4.6) Unchanged	5.1 Employees (FTE) 2025: 5.1 ▲ 0.4 vs 2024 (4.7) Unchanged	▲ 0.4

Key figures of Medtradex, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Medtradex?

What happened at Medtradex in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 22, 2026 New annual accounts for financial year 2025: profit of € 14,423 (▼ 77% vs 2024). Source: NBB ↗
Sep 27, 2018 New establishment in Leuven. KBO
Jul 27, 2018 New establishment in Oud-Heverlee. KBO
2018 Céline Simonet became a director. NBB
2018 Ivo Schapdryver became a director. NBB
Jul 27, 2018 Start of the company according to the CBE. KBO

In short

From € 289,528 profit in 2022 to € 14,423 profit in 2025.

Paid € 220,798 in corporate taxes since 2022.

Best year ever: 2022, with € 289,528 profit.

On average € 116,400 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Céline Simonet Ivo Schapdryver

CnI

Medtradex

Behind Medtradex are Céline Simonet and Ivo Schapdryver. The same people are also behind CnI.

Directors

According to the 2025 annual accounts

Céline Simonet

Manager

Also active at: CnI

since 2018

Ivo Schapdryver

Manager

Also active at: CnI

since 2018

Establishments

Establishment units

Physical locations of this company

Registered office

Korbeekdamstraat 30A

3050 Oud-Heverlee

2.280.122.283

Wijgmaalsesteenweg 96 box C

3012 Leuven

Active since 27 September 2018

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

CnI same network

€ 66,768 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0700.451.252

VAT number

BE 0700.451.252

Registered office

Korbeekdamstraat 30A, 3050 Oud-Heverlee

Names & denominations

Medtradex

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

27 July 2018

Peppol

Active · Active since 12 Mar 2026

Activities · NACE

Groothandel in farmaceutische en medische artikelen

Handelsbemiddeling in de groothandel in andere specifieke goederen

Overige posterijen en koeriers

View on CBE Public ↗ Annual accounts (NBB) ↗

Medtradex

Financials

What happened to Medtradex?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions